ATE388239T1 - Cgt1 als antifungales target - Google Patents
Cgt1 als antifungales targetInfo
- Publication number
- ATE388239T1 ATE388239T1 AT03786098T AT03786098T ATE388239T1 AT E388239 T1 ATE388239 T1 AT E388239T1 AT 03786098 T AT03786098 T AT 03786098T AT 03786098 T AT03786098 T AT 03786098T AT E388239 T1 ATE388239 T1 AT E388239T1
- Authority
- AT
- Austria
- Prior art keywords
- cgt1
- antifungal
- antifungal target
- target
- guanylyltransferase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0228699.5A GB0228699D0 (en) | 2002-12-09 | 2002-12-09 | Novel therapeutic target |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE388239T1 true ATE388239T1 (de) | 2008-03-15 |
Family
ID=9949352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03786098T ATE388239T1 (de) | 2002-12-09 | 2003-12-09 | Cgt1 als antifungales target |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060172368A1 (de) |
EP (1) | EP1573050B1 (de) |
AT (1) | ATE388239T1 (de) |
AU (1) | AU2003295098A1 (de) |
DE (1) | DE60319582T2 (de) |
ES (1) | ES2302968T3 (de) |
GB (1) | GB0228699D0 (de) |
WO (1) | WO2004053149A1 (de) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
US6232070B1 (en) * | 1998-11-09 | 2001-05-15 | Stewart Shuman | Pharmacological targeting of mRNA cap formation |
-
2002
- 2002-12-09 GB GBGB0228699.5A patent/GB0228699D0/en not_active Ceased
-
2003
- 2003-12-09 US US10/537,582 patent/US20060172368A1/en not_active Abandoned
- 2003-12-09 WO PCT/GB2003/005366 patent/WO2004053149A1/en active IP Right Grant
- 2003-12-09 AU AU2003295098A patent/AU2003295098A1/en not_active Abandoned
- 2003-12-09 AT AT03786098T patent/ATE388239T1/de not_active IP Right Cessation
- 2003-12-09 EP EP03786098A patent/EP1573050B1/de not_active Expired - Lifetime
- 2003-12-09 ES ES03786098T patent/ES2302968T3/es not_active Expired - Lifetime
- 2003-12-09 DE DE60319582T patent/DE60319582T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB0228699D0 (en) | 2003-01-15 |
US20060172368A1 (en) | 2006-08-03 |
EP1573050A1 (de) | 2005-09-14 |
DE60319582T2 (de) | 2009-03-19 |
DE60319582D1 (de) | 2008-04-17 |
AU2003295098A1 (en) | 2004-06-30 |
WO2004053149A1 (en) | 2004-06-24 |
EP1573050B1 (de) | 2008-03-05 |
ES2302968T3 (es) | 2008-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
NO20066050L (no) | Substituerte indazoler, sammensetninger inneholdende disse samt fremstilling og anvendelse derav | |
DE602005024274D1 (de) | Als aurora-kinase-inhibitoren nutzbare thienopyrimidine | |
NO20072058L (no) | Inhibitorer av interaksjonen mellom MDM2 og P53 | |
NO20052496D0 (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter. | |
NO20091734L (no) | Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse | |
ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
IL172924A0 (en) | 3.5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation | |
NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
NO20044261L (no) | Indazoler substituerte med en anticanceros aktivitet | |
BRPI0507794A (pt) | métodos de modular a atividade de il-23, reagentes relacionados | |
ATE387435T1 (de) | Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren | |
UY28348A1 (es) | Compuestos novedosos | |
MX2007008723A (es) | Polipeptidos de yersinia spp y metodos de uso. | |
BRPI0515721A (pt) | uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação | |
EA200602017A1 (ru) | КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ | |
UY28344A1 (es) | Nuevos compuestos | |
PA8577701A1 (es) | Polipeptido t20 pegilado | |
MXPA04004018A (es) | Metodos de separacion por exclusion para toxicidad de compuestos de prueba. | |
AU2003223634A1 (en) | Peptide deformylase inhibitors | |
ATE388239T1 (de) | Cgt1 als antifungales target | |
NO20033921L (no) | Inhibitor av monoaminopptak | |
ATE430206T1 (de) | Mss4 als antifungisches zielmolekül | |
TW200724152A (en) | Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |